Nidan Laboratories And Healthcare Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

13.90

13.90

9.90

9.90

9.90

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

55.54

52.00

3.43

1.13

0.41

Loan funds

Secured loans

10.93

19.29

38.05

34.35

32.17

Unsecured loans

-

-

-

-

-

Total

80.37

85.19

51.38

45.38

42.48

Uses of funds

Fixed assets

Gross block

60.53

59.64

58.27

55.28

55.27

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

39.14

39.18

38.35

35.20

32.01

Net block

21.39

20.46

19.92

20.08

23.26

Capital work-in-progress

-

3.81

0.23

-

-

Investments

-

29.54

0.27

0.53

-

Net current assets

Current assets, loans & advances

63.01

34.67

33.33

24.60

19.80

Less : current liabilities & provisions

4.03

3.29

2.36

-0.17

0.57

Total net current assets

58.98

31.38

30.96

24.77

19.22

Miscellaneous expenses not written

-

-

-

-

-

Total

80.37

85.19

51.38

45.38

42.48

Notes:

Book value of unquoted investments

-

28.54

0.27

0.53

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

139.00

139.00

99.00

99.00

99.00